THE 2016 Pat Clear Award, has
been won by Zarli French, senior
manager external affairs at MSD
where she has worked for 30 years.The above snippet is the first part of an article sent to subscribers in Pharmacy Daily's issue from 05 Apr 16 To see the full story, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 05 Apr 16
CONSUMERS and health professionals are advised that Biogen Australia, in consultation with the Therapeutic Goods Administration (TGA), will withdraw multiple sclerosis therapy Zinbryta (daclizumab) from the Australian market following a review of cases of serious inflammatory brain disorders in Europe (PD 05 Mar).